Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)
October 04 2021 - 4:38PM
Edgar (US Regulatory)
Filed pursuant to Rule 433
Issuer Free Writing Prospectus dated October 4, 2021
Relating to Preliminary Prospectus Supplement dated October 4, 2021
and Prospectus dated September 22, 2021
File No. 333-259726
The following pricing notification is provided for your convenience and information. The information herein is qualified in its entirety by reference to
the preliminary prospectus supplement and accompanying prospectus relating to the security. Capitalized terms used but not defined herein have the meaning ascribed to them in the preliminary prospectus supplement and accompanying prospectus.
Pricing Notification The Gabelli Dividend & Income Trust
|
|
|
Issuer:
|
|
The Gabelli Dividend & Income Trust (GDV) (the Fund)
|
|
|
Security:
|
|
4.250% Series K Cumulative Preferred Shares (Liquidation Preference $25.00 Per Share) (Series K Preferred Shares)
|
|
|
Format:
|
|
SEC Registered
|
|
|
Anticipated Listing / Ticker:
|
|
NYSE Listed / GDV PrK
|
|
|
Size:
|
|
$150,000,000 (6 million shares)
|
|
|
Dividend:
|
|
4.250% (fixed-for-life)
|
|
|
Expected Ratings*:
|
|
Aa3 from Moodys Investors Service, Inc. (No assurances can be given that the anticipated rating will be obtained from Moodys Investors Service, Inc.)
|
|
|
Maturity:
|
|
Perpetual
|
|
|
Trade Date:
|
|
October 4, 2021
|
|
|
Settlement Date:
|
|
October 7, 2021 (T+3)
|
|
|
Dividends:
|
|
Dividends on the Series K Preferred Shares will be payable quarterly in arrears on March 26, June 26, September 26 and December 26, commencing December 26, 2021
|
|
|
Optional Redemption:
|
|
Non-call 5, par call on or after October 7, 2026
|
|
|
Use of Proceeds:
|
|
The Fund intends to use a portion of the net proceeds from this offering to redeem all or a portion of the Funds outstanding 5.25% Series G Cumulative Preferred Shares and the remaining proceeds will be used to purchase
portfolio securities in accordance with the Funds investment objectives and policies.
|
|
|
QDI/DRD:
|
|
Refer to the Funds base prospectus dated September 22, 2021.
|
|
|
|
Joint Bookrunners:
|
|
BofA Securities (physical), Morgan Stanley
|
|
|
Co-Manager:
|
|
G.research
|
|
|
SEC Filing:
|
|
Yes
|
|
|
CUSIP / ISIN:
|
|
36242H 864 / US36242H8640
|
*Note: A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or
withdrawal at any time.
The Fund has filed a registration statement (including a base prospectus (including the statement of additional
information) and preliminary prospectus supplement) with the SEC for the offering to which this communication relates. Before you invest, you should read the preliminary prospectus supplement in that registration statement and other documents the
Fund has filed with the SEC for more complete information about the Fund and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the Fund, any underwriter participating in the
offering, or any dealer participating in the offering will arrange to send you the preliminary prospectus supplement if you request it by calling BofA Securities, Inc. toll-free at 1-800-294-1322 or Morgan Stanley & Co LLC toll-free at 1-866-718-1649.
The information herein and in the preliminary prospectus supplement is not complete and is subject to change. This document, the base prospectus,
and the preliminary prospectus supplement are not offers to sell these securities and are not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted. Investors should consider the Funds
investment objectives, risks, charges and expenses carefully before investing. The preliminary prospectus supplement and related base prospectus contain this and additional information about the Fund and the Series K Preferred Shares, and should be
read carefully before investing.
An investment in the Series K Preferred Shares involves risks. Therefore, before investing in the Series K
Preferred Shares you should consider the risks associated with such an investment carefully. See Special Characteristics and Risks of the Series K Preferred Shares in the preliminary prospectus supplement and Risk Factors and
Special Considerations in the related base prospectus.
Gabelli Dividend and Inc... (NYSE:GDV-G)
Historical Stock Chart
From Jul 2024 to Aug 2024
Gabelli Dividend and Inc... (NYSE:GDV-G)
Historical Stock Chart
From Aug 2023 to Aug 2024